IP Library Granted Patent US 6,955,174
Granted Patent B2
US 6,955,174 · App. 10/387,347 · Granted Oct 18, 2005

Cryotherapy method for detecting and treating vulnerable plaque

Assignee: Uryovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,955,174
App. No.
10/387,347
Granted
Oct 18, 2005
Kind
B2
Abstract

Methods, apparatus, and kits detect and/or treat vulnerable plaque of a blood vessel. A temperature differential can be sensed along a lumen surface with temperature sensors on a balloon filled with warm gas. Treatment methods include controlled and safe cryogenic cooling of vulnerable plaque to inhibit release of retained fluid within the vulnerable plaque so as to inhibit acute coronary syndrome and to help maintain patency of a body lumen.

Claims (29)

1. A method for treating vulnerable plaque of a blood vessel, the vulnerable plaque releasably retaining fluid, said method comprising:

identifying a portion of the vasculature for inhibiting release of the retained fluid;

determining a plaque location is within the identified portion of the vasculature;

introducing a catheter into a lumen of the blood vessel and positioning a balloon of the catheter within the vessel lumen adjacent the vulnerable plaque; and

in response to the determining step, selectively cooling the vulnerable plaque at the plaque location to a temperature sufficient to inhibit release of the retained fluid into the blood vessel by introducing cooling fluid into the balloon of the balloon catheter so that the temperature of an outer surface of the balloon is in a range from about 10° C. to −40° C. for a time period in a range from about 15 to 120 seconds.

2. A method as in claim 1 , further comprising differentiating the vulnerable plaque from standard stenotic plaque.

3. A method as in claim 2 , wherein the differentiating step comprises sensing a temperature of a tissue adjacent the balloon while the balloon is inflated with a gas.

4. A method as in claim 3 , wherein the differentiating step further comprises inflating the balloon so that a temperature of the gas within the balloon is at a first temperature, and wherein the cooling step comprises cooling an outer surface the balloon to a second temperature less than the first temperature.

5. A method as in claim 3 , wherein the differentiating step further comprises inflating the balloon so that a temperature of the gas within the balloon is about 20° C. or more.

6. A method as in claim 1 , wherein the blood vessel is an artery.

7. A method as in claim 1 , wherein the fluid of the vulnerable plaque comprises a lipid-rich liquid, and wherein the vulnerable plaque comprises a cap of cells between the lipid-rich liquid and a lumen of the blood vessel.

8. A method as in clam 7 , further comprising inhibiting apoptosis of tissue adjacent the lipid-rich liquid.

9. A method as in claim 8 , wherein the cooling step inhibits rupture of the cap of cells.

10. A method as in claim 7 , further comprising stabilizing the vulnerable plaque by cooling the lipid-rich liquid to a highly ordered hexagonal lattice.

11. A method as in claim 10 , wherein the lipid-rich liquid is hardened to at least a gel-state.

12. A method as in claim 7 , further comprising passivating the vulnerable plaque.

13. A method as in claim 12 , wherein passivation comprises at least one of: reducing a size or modifying a consistency or composition of the lipid-rich liquid; altering the chemistry or life cycle of the vulnerable plaque; and increasing a thickness of the cap of cells.

14. A method as in claim 1 , wherein the cooling inhibits inflammation of the vulnerable plaque or deterioration of the vulnerable plaque.

15. A method as in claim 1 , further comprising treating the vulnerable plaque with at least one of angioplasty, stenting, and atherectomy.

16. A kit for treating vulnerable plaque of a blood vessel, the vulnerable plaque releasably retaining fluid, the kit comprising:

a catheter having a proximal end, a distal end, and a cooling member; and

instructions for use of the catheter according to claim 1 .

17. A method for treating vulnerable plaque of a blood vessel, the vulnerable plaque releasably retaining fluid, said method comprising:

detecting the vulnerable plaque with a balloon catheter by inflating a balloon of the balloon catheter so that a gas within the balloon is at a temperature of about 30° C. or more; and

cooling the vulnerable plaque, with the balloon catheter, to a temperature sufficient to inhibit release of the retained fluid into the blood vessel.

18. A method as in claim 17 , wherein the cooling step comprises cooling an outer surface of the balloon to a temperature of about 10° C. or less.

19. A kit for detecting vulnerable plaque of a blood vessel, the kit comprising:

a catheter having a proximal end, a distal end, and a balloon member with a plurality of temperature sensors near its distal end; and

instructions for use of the catheter according to claim 18 .

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2010
From: CRYOVASCULAR SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 024626/0933 →
TERMINATION OF PATENT SECURITY INTEREST Recorded Apr 25, 2005
From: PRESIDIO MANAGEMENT GROUP, INC., AS COLLATERAL AGENT
To: CRYOVASCULAR SYSTEMS, INC.
Reel/Frame 015931/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2003
From: JOYE, JAMES; TATSUTANI, KRISTINE; WILLIAMS, JOSEPH J.
To: CRYO VASCULAR SYSTEMS, INC.
Reel/Frame 013860/0275 →
SECURITY INTEREST Recorded May 23, 2003
From: CRYOVASCULAR SYSTEMS, INC.
To: PEQOUT PRIVATE EQUITY FUND III, L.P.; USVP V. INTERNATIONAL L.P.; USVP V ENTREPRENEUR PARTNERS, L.P.; U.S. VENTURE PARTNERS V, L.P.; 2180 ASSOCIATES FUND V, L.P.; DENOVO (Q) VENTURES I, L.P.; DEVOVO VENTURES, I, L.P.; GUIDANT INVESTMENT CORPORATION; SARATOGA VENTURES III, L.P.; SAPIENT CAPITAL, L.P.
Reel/Frame 014097/0141 →
Continuity (2)
Continuation In Part 0964146200 · Aug 18, 2000
Related Publication 20040002749A1 · Jan 1, 2004